| Application no. and date | 18769510.1 (espacenet) (Federated) (European Patent Register), 20180830 | | Patent/reg. no. and date | DK/EP 3675854, 20250122 | | Publication date | 20200708 | | Priority no. and date | EP 17188870, 20170831 | | EP pub. no. and date |
EP 3675854 20200708 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 170939/SH/CB | | Inventor | EDER, Jörg, Novartis Pharma AG
Novartis Institutes for Biomed. Research
Postfach
4002 Basel, CH,
HARRISON, Richard Alexander, Brookwood
Carding Mill Valley
Church Stretton
Shropshire SY6 6JE, GB,
HARALDSSON, Boerje, Novartis Pharma AG
Postfach
4002 Basel, CH,
SCHUBART, Anna Svenja, Novartis Pharma AG
Novartis Institutes for Biomed. Research
Postfach
4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/454 (2006.01) , A61P 13/12 (2006.01) | | Title | PIPERIDINYL-INDOLDERIVATIVER TIL ANVENDELSE VED BEHANDLING AF C3-GLOMERULOPATI | | Int. application no. | IB2018056618 | | Int. publication no. | WO2019043609 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
